LDL-cholesterol targets as Achilles' heel of 2020 ISH guidelines.
作者信息
Filipiak Krzysztof J
机构信息
1st Department of Cardiology, Medical University of Warsaw, Poland.
出版信息
Int J Cardiol Hypertens. 2021 Jan 14;8:100078. doi: 10.1016/j.ijchy.2021.100078. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
LDL-cholesterol targets as Achilles' heel of 2020 ISH guidelines.低密度脂蛋白胆固醇目标作为2020年ISH指南的致命弱点。
Int J Cardiol Hypertens. 2021 Jan 14;8:100078. doi: 10.1016/j.ijchy.2021.100078. eCollection 2021 Mar.
2
Is myopathy the Achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice.肌病是他汀类药物的致命弱点吗？：新胆固醇治疗指南与日常临床实践的差异
J Am Coll Cardiol. 2014 Jun 3;63(21):2300-1. doi: 10.1016/j.jacc.2013.12.047. Epub 2014 Mar 5.
3
Reply: is myopathy the achilles' heel of statins?: differences between the new cholesterol treatment guidelines and everyday clinical practice.回复：肌病是他汀类药物的致命弱点吗？：新胆固醇治疗指南与日常临床实践的差异
J Am Coll Cardiol. 2014 Jun 3;63(21):2301. doi: 10.1016/j.jacc.2014.02.532. Epub 2014 Mar 5.
4
Achilles' death: anatomical considerations regarding the most famous trauma of the Trojan War.阿喀琉斯之死：有关特洛伊战争中最著名创伤的解剖学思考。
J Trauma Acute Care Surg. 2013 Mar;74(3):946-7. doi: 10.1097/TA.0b013e31828272ad.
5
Antibiotics: Achilles' heel of the Achilles' tendon.抗生素：跟腱的阿喀琉斯之踵。
Harv Health Lett. 2004 Jan;29(3):7.
6
Cholesterol: An Achilles' Heel for Glioblastoma?胆固醇：胶质母细胞瘤的阿喀琉斯之踵？
Cancer Cell. 2016 Nov 14;30(5):653-654. doi: 10.1016/j.ccell.2016.10.011.
7
Reply to "Targeting cholesterol homeostasis through inhibiting: An Achilles' heel for glioblastoma?".对《通过抑制作用靶向胆固醇稳态：胶质母细胞瘤的致命弱点？》的回复
Neuro Oncol. 2023 Nov 2;25(11):2103-2104. doi: 10.1093/neuonc/noad146.
8
Manpower; the Achilles' heel in public health.人力：公共卫生的致命弱点。
Am J Public Health Nations Health. 1957 Nov;47(11 Pt 1):1390-8. doi: 10.2105/ajph.47.11_pt_1.1390.
9
Admissions and discharges, Achilles' heel of public relations. II.入院与出院：公关的致命弱点。二。
Hosp Manage. 1961 Oct;92:34-5 passim.
10
Admissions and discharges, Achilles' heel of public relations. I.入院与出院：公关的致命弱点。一
Hosp Manage. 1961 Sep;92:36-8.
本文引用的文献
1
2020 International Society of Hypertension global hypertension practice guidelines.2020年国际高血压学会全球高血压实践指南
J Hypertens. 2020 Jun;38(6):982-1004. doi: 10.1097/HJH.0000000000002453.
2
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南：通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
3
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会（ESC）与欧洲糖尿病研究协会（EASD）合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.
4
Recommendation for the management of dyslipidemia in Poland - Third Declaration of Sopot. Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.波兰血脂异常管理建议——索波特第三次声明。由波兰心脏学会心血管药物治疗工作组认可的跨学科专家立场声明。
Cardiol J. 2018;25(6):655-665. doi: 10.5603/CJ.2018.0141.
5
[A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population].[针对波兰人群校准的新版心血管风险评估系统及风险图表]
Kardiol Pol. 2015;73(10):958-61. doi: 10.5603/KP.2015.0182.
Zotero 插件